Searchable abstracts of presentations at key conferences in endocrinology

ea0042il10 | Metabolism in Prostate Cancer | Androgens2016

Causes and consequences of metabolic changes in prostate tumours

Massie Charles

Metabolic alterations have long been known to occur in the transition to prostate cancer, from alterations in central metabolism to lipid metabolism and local steroid biosynthesis. However the upstream events that lead to these alterations have not been comprehensively assessed. In this presentation I will draw together genomic, epigenomic and transcriptomic analysis, together with metabolic profiling. Overlaying the effects of androgen signaling on these pathways and metaboli...

ea0049ep505 | Diabetes complications | ECE2017

A Review of the literature: What are the impacts of hypoglycaemia in insulin-dependent diabetic adults?

O'Donovan Charles , O'Donovan Olivia

Background: The prevalence of diabetes has reached epidemic proportions and according to the World Health Organisation (WHO) more than 220 million people worldwide have diabetes. The main complication in insulin-dependent diabetes mellitus (IDDM) patients is hypoglycaemia, with approximately 90% of all IDDM patients having experienced a hypoglycaemic episode. Hypoglycaemia has a substantial clinical impact in terms of mortality, morbidity and quality of life.<p class="abst...

ea0016p123 | Clinical cases | ECE2008

Fungal thyroiditis

Narasimhan Sowmya , Gibbs Charles

Case: A 38-year-old HIV positive lady presented with a neck swelling and neutropenic sepsis. Examination of the neck revealed a firm diffuse non-tender goitre with cervical lymphadenopathy. She also had generalised lymphadenopathy, splenomegaly and miliary opacities in the lungs on the chest radiograph. Disseminated cryptococcal infection was diagnosed following isolation of the organism in blood and bone marrow. A radioisotope scan of the thyroid showed no uptake in the right...

ea0014p386 | (1) | ECE2007

Congenital hypothyroidism – results of a protocol implemented &br;1993–2006

Melo Miguel , Buchanan Charles

Introduction: A new Regional Paediatric Endocrine Service was established in 1993 which implemented a protocol for Congenital Hypothyroidism (CH) management. Its aim is to confirm the diagnosis, establish aetiology and start treatment within 48 hours after the result of the screening test.Objective: To audit the results of this protocol.Methods: Case note and laboratory data review for all Neonates referred since 1993 after a posit...

ea0074ncc40 | Highlighted Cases | SFENCC2021

A Lady with thyrotoxicosis and rapidly growing goiter

Samarasinghe Gayani Pramuditha , Antonipillai Charles

Case history: A 62 years old lady presented with a history of weight loss, sweating, and tremor for 3 months. The diagnosis of thyrotoxicosis was made following biochemical confirmation and she was started on carbimazole 20 mg twice a day. Several weeks later she got admitted with progressive shortness of breath, hoarseness of voice, and a painful neck lump. Examination revealed a firm to hard fixed multinodular goiter with a dominant hard nodule at the left upper pole. There ...

ea0055wg2 | Workshop G: Disorders of the parathyroid glands, calcium metabolism and bone | SFEEU2018

Refractory hypocalcaemia due to pseudo hypoparathyroidism

Saqib Aaisha , Tremble Jennifer , Charles Debbie-Ann

A 27 year old, Caucasian female was admitted with vomiting and found to have severe hypocalcaemia. On clinical examination she had a normal stature, oval face; she was not brachydactylic and did not have dental hypoplasia. Biochemically she had serum Ca of 1.49 mmol/l (2.15–2.50), a high serum Phosphate of 1.50 mmol/l (0.9–1.45) and Vitamin D levels of 59 nmol/l (>50 sufficient for majority population). Her serum parathyroid hormone was elevated at 304.5 ng/l (15...

ea0050p262 | Neuroendocrinology and Pituitary | SFEBES2017

Establishing the prevalence of pituitary involvement in patients with IgG4-related disease.

Smith Christopher , Pusey Charles , Wernig Florian

Background: IgG4-related disease is a rare immune-mediated inflammatory condition associated with extensive multi-organ involvement. Little is known about the epidemiology of pituitary involvement as a part the IgG4-related disease spectrum.Objectives: We aimed to identify patients with pituitary involvement amongst those with systemic IgG4-related disease, and to compare these individuals to patients with isolated ...

ea0050p262 | Neuroendocrinology and Pituitary | SFEBES2017

Establishing the prevalence of pituitary involvement in patients with IgG4-related disease.

Smith Christopher , Pusey Charles , Wernig Florian

Background: IgG4-related disease is a rare immune-mediated inflammatory condition associated with extensive multi-organ involvement. Little is known about the epidemiology of pituitary involvement as a part the IgG4-related disease spectrum.Objectives: We aimed to identify patients with pituitary involvement amongst those with systemic IgG4-related disease, and to compare these individuals to patients with isolated ...

ea0059p030 | Adrenal and steroids | SFEBES2018

Analysing management and follow up of adrenal incidentalomas

Saqib Aaisha , Tremble Jennifer , Charles Debbie-Ann

Objective: Based on recommendations from the Clinical Practice Guidelines committee group on management of adrenal incidentalomas our project aims to review whether patients found to have adrenal incidentalomas were managed as per recommendations of the committee as follows: If they had a 1 mg overnight dexamethasone suppression test,were they tested for phaeochromocytoma, whether the investigations were used judiciously keeping in view patients co-morbid state, were any of th...

ea0034p373 | Steroids | SFEBES2014

Dutasteride and 5α-reductase type 1 activity: for androgens only?

West Charles , Vincent Royce , Taylor Norman

Background: Three 5α-reductase (5α-R1-3) isoenzymes are described. In humans, 5α-R2 deficiency (5α-R2D) causes pseudohermaphroditism and 5α-R3 neurological defects. The role of 5α-R1 is not clear. Urine steroid profiling (USP) by GC–MS can compare 5α-reduction activity based on excretion of 5α- and 5β-reduced metabolite ratios. Finasteride predominantly inhibits 5α-R2. USP in these patients shows concordance with 5α-R...